DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: 067080)

DAE HWA Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Oct 10, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Market Capitalization	341,575	222,772	350,150	437,688	412,294	656,846
Market Cap Growth	-57.67%	-36.38%	-20.00%	6.16%	-37.23%	427.66%
Enterprise Value	197,042	271,655	388,012	484,753	463,521	683,200
Last Close Price	19500.00	12002.73	18360.31	22778.29	21352.34	33896.06
PE Ratio	31.57	20.00	48.84	31.81	101.20	153.38
PS Ratio	2.95	1.94	3.18	3.58	2.90	4.72
PB Ratio	4.25	2.65	4.21	5.24	5.62	10.64
P/FCF Ratio	-11.27	-17.77	61.69	118.84	86.66	-486.30
P/OCF Ratio	-58.19	-5423.83	33.38	40.00	46.91	270.23
EV/Sales Ratio	1.71	2.37	3.52	3.97	3.26	4.91
EV/EBITDA Ratio	16.79	23.86	40.38	39.39	49.94	74.59
EV/EBIT Ratio	33.20	47.47	75.62	59.72	85.77	122.21
EV/FCF Ratio	-14.54	-21.67	68.36	131.62	97.43	-505.81
Debt / Equity Ratio	0.62	0.61	0.54	0.59	0.68	0.54
Debt / EBITDA Ratio	4.44	4.53	4.68	4.00	5.34	3.67
Debt / FCF Ratio	-3.84	-4.11	7.92	13.37	10.42	-24.88
Asset Turnover	0.66	0.70	0.67	0.77	1.02	1.12
Inventory Turnover	3.99	4.19	4.63	4.74	4.96	4.86
Quick Ratio	0.39	0.45	0.56	0.59	0.65	0.68
Current Ratio	0.68	0.70	0.82	0.81	0.95	1.16
Return on Equity (ROE)	11.26%	10.85%	7.62%	15.44%	5.56%	6.84%
Return on Assets (ROA)	2.12%	2.18%	1.96%	3.18%	2.43%	2.81%
Return on Capital (ROIC)	2.64%	2.71%	2.46%	3.97%	3.09%	3.74%
Earnings Yield	3.17%	4.73%	1.90%	2.89%	0.90%	0.60%
FCF Yield	-3.97%	-5.63%	1.62%	0.84%	1.15%	-0.21%
Dividend Yield	0.77%	1.25%	0.82%	-	-	-
Payout Ratio	8.22%	25.16%	39.90%	13.95%	47.35%	45.15%
Buyback Yield / Dilution	-3.43%	-3.42%	-0.06%	0.01%	0.12%	-4.07%
Total Shareholder Return	-2.66%	-2.17%	0.76%	0.01%	0.12%	-4.07%

Source: S&P Capital IQ. Standard template. Financial Sources.